ASSAY RECORD
Results
Showing up to 20 records.
| NO. | RECORD ID | NAME | SEQUENCE | SOURCE ORGANISM | FUNCTION CATEGORY | TARGET ORGANISM | ACTIVITY | ASSAY METHOD | PMID | PATENT NO | VERIFICATION STATUS |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 418961 | Rec_0431619 | WESLSRLLG (WG-9) |
WESLSRLLG |
Struthio camelus [Animal] |
Antioxidant, Radical scavenging |
superoxide radical |
160±6.4 μg/mL | IC50 |
28911587 | - |
YES |
| 418962 | Rec_0431620 | WESLSRLLG (WG-9) |
WESLSRLLG |
Struthio camelus [Animal] |
Antioxidant, Radical scavenging |
hydroxyl radical |
150±6.7 μg/mL | IC50 |
28911587 | - |
YES |
| 418963 | Rec_0431621 | alpha-ENaC PY motif peptide |
TAPPPAYATLG |
synthetic construct [Synthetic] |
Protein-binding, NEDD4-1 WW3 binding |
human NEDD4-1 WW3 domain |
- | NMR protein-peptide complex structure |
23665454 | - |
YES |
| 418964 | Rec_0431622 | Tenmo-PK-1 |
HVVNFTPRL |
Tenebrio molitor [Animal] |
Neuropeptide, Myoinhibitory, Myotropic |
Tenebrio molitor oviduct |
- | oviduct myotropic bioassay |
22542898 | - |
YES |
| 418965 | Rec_0431623 | Tenmo-PK-1 |
HVVNFTPRL |
Tenebrio molitor [Animal] |
Neuropeptide |
Tenebrio molitor heart |
- | heart myotropic bioassay (no response reported) |
22542898 | - |
YES |
| 418966 | Rec_0431624 | Amyloid beta peptide 1-16 (Aβ(1-16)) |
DAEFRHDSGYEVHHQK |
Homo sapiens [Animal] |
Metal binding, Zinc binding |
Zn(II) |
- | zinc-binding structural/NMR assay |
16301322 | - |
YES |
| 418967 | Rec_0431625 | L-amino-acid oxidase |
ADDRNPLAECFQENDYEEFLEIARNGLKATSNPKHVVIVGAGMAGLSAAYVLAGAGHQVTVLEASERPGGRVRTYRNEEAGWYANLGPMRLPEKHRIVREYIRKFDLRLNEFSQENDNAWYFIKNIRKKVGEVKKDPGLLKYPVKPSEAGKSAGQLYEESLGKVVEELKRTNCSYILNKYDTYSTKEYLIKEGDLSPGAVDMIGDLLNEDSGYYVSFIESLKHDDIFAYEKRFDEIVDGMDKLPTAMYRDIQDKVHFNAQVIKIQQNDQKVTVVYETLSKETPSVTADYVIVCTTSRAVRLIKFNPPLLPKKAHALRSVHYRSGTKIFLTCTTKFWEDDGIHGGKSTTDLPSRFIYYPNHNFTNGVGVIIAYGIGDDANFFQALDFKDCADIVFNDLSLIHQLPKKDIQSFCYPSVIQKWSLDKYAMGGITTFTPYQFQHFSDPLTASQGRIYFAGEYTAQAHGWIDSTIKSGLRAARDVNLASENPSGIHLSNDNEL |
Agkistrodon rhodostoma [Animal] |
Enzymatic, Oxidoreductase, L-amino-acid oxidase |
L-amino-acid substrates |
- | L-amino-acid oxidase enzymatic activity assay |
8080286;11248687 | - |
YES |
| 418968 | Rec_0431626 | peptide 1022 (LRIRVIVWR) |
LRIRVIVWR |
synthetic construct [Synthetic] |
Immunomodulatory, Chemokine-inducing |
human peripheral blood mononuclear cells (PBMC); MCP-1 |
52 pg/mL | capture ELISA chemokine induction |
- | US 9,707,282 B2 |
YES |
| 418969 | Rec_0431627 | peptide 1022 (LRIRVIVWR) |
LRIRVIVWR |
synthetic construct [Synthetic] |
Immunomodulatory, Chemokine-inducing |
human peripheral blood mononuclear cells (PBMC); MCP-1 |
983 pg/mL | capture ELISA chemokine induction |
- | US 9,707,282 B2 |
YES |
| 418970 | Rec_0431628 | peptide 1022 (LRIRVIVWR) |
LRIRVIVWR |
synthetic construct [Synthetic] |
Immunomodulatory, Chemokine-inducing |
human peripheral blood mononuclear cells (PBMC); MCP-3 |
0 pg/mL | capture ELISA chemokine induction |
- | US 9,707,282 B2 |
YES |
| 418971 | Rec_0431629 | peptide 1022 (LRIRVIVWR) |
LRIRVIVWR |
synthetic construct [Synthetic] |
Immunomodulatory, Chemokine-inducing |
human peripheral blood mononuclear cells (PBMC); MCP-3 |
1 pg/mL | capture ELISA chemokine induction |
- | US 9,707,282 B2 |
YES |
| 418972 | Rec_0431630 | peptide 1022 (LRIRVIVWR) |
LRIRVIVWR |
synthetic construct [Synthetic] |
Immunomodulatory, Chemokine-inducing |
human peripheral blood mononuclear cells (PBMC); Gro-α |
10 pg/mL | capture ELISA chemokine induction |
- | US 9,707,282 B2 |
YES |
| 418973 | Rec_0431631 | peptide 1022 (LRIRVIVWR) |
LRIRVIVWR |
synthetic construct [Synthetic] |
Immunomodulatory, Chemokine-inducing |
human peripheral blood mononuclear cells (PBMC); Gro-α |
64 pg/mL | capture ELISA chemokine induction |
- | US 9,707,282 B2 |
YES |
| 418974 | Rec_0431632 | peptide 1022 (LRIRVIVWR) |
LRIRVIVWR |
synthetic construct [Synthetic] |
Antimicrobial, Antibiofilm |
Pseudomonas aeruginosa |
56 % | biofilm inhibition assay |
- | WO 2015/038339 A1 |
YES |
| 418975 | Rec_0431633 | peptide 1022 (LRIRVIVWR) |
LRIRVIVWR |
synthetic construct [Synthetic] |
Antimicrobial, Antibiofilm |
methicillin-resistant Staphylococcus aureus (MRSA) |
15 % | biofilm inhibition assay |
- | WO 2015/038339 A1 |
YES |
| 418976 | Rec_0431634 | VIR-590 |
LEAIPMKIPPEFLFGKPFVF |
synthetic construct [Synthetic] |
Antiviral, Anti-HIV |
HIV-1 NL4-3 |
343 nM | IC50 (HIV-1 infection assay) |
- | US 7,655,629 B2 |
YES |
| 418977 | Rec_0431635 | GH9 |
HGHGHGHGH |
synthetic construct [Synthetic] |
Antimicrobial, Antibacterial |
Pseudomonas aeruginosa ATCC 10145 |
99 μM | MBC99 (CFU bactericidal assay) |
- | US 2020/0115426 A1 |
YES |
| 418978 | Rec_0431636 | GH9 |
HGHGHGHGH |
synthetic construct [Synthetic] |
Antimicrobial, Antibacterial |
Pseudomonas aeruginosa ATCC 10145 |
>400 μM | MBC100 (CFU bactericidal assay) |
- | US 2020/0115426 A1 |
YES |
| 418979 | Rec_0431637 | Hydra-RFamide I |
EWLGGRF |
- |
- |
- |
- | - |
- | - |
- |
| 418980 | Rec_0431638 | Crenezumab |
EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYGMSWVRQAPGKGLELVASINSNGGSTYYPDSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCASGDYWGQGTTVTVSSASTKGPSVFPLAPCSRSTSESTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTKTYTCNVDHKPSNTKVDKRVESKYGPPCPPCPAPEFLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSQEDPEVQFNWYVDGVEVHNAKTKPREEQFNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKGLPSSIEKTISKAKGQPREPQVYTLPPSQEEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSRLTVDKSRWQEGNVFSCSVMHEALHNHYTQKSLSLSLG |
- |
- |
- |
- | - |
- | - |
- |